- Supported exchanges /
- TWO /
- 6976.TWO
Acepodia, Inc. (6976 TWO) stock market data APIs
Acepodia, Inc. operates as a clinical stage biotechnology company. The company engages in developing cell therapies with its antibody cell conjugation (ACC) platform technology to address gaps in cancer care. It links tumor targeting antibodies to its proprietary immune cells, such as gamma delta 2 T cells to create novel ACE therapies. It develops ACE 1831 targeting CD20 that is in phase 1 clinical trial; ACE 2016 targeting EGFR, which is in preclinical study; ACE1708; and ACE1702 targeting HER2 that is in phase 1 clinical trial. Acepodia Inc. has strategic clinical collaboration with Pfizer Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. The company is headquartered in Grand Cayman, the Cayman Islands.
Acepodia, Inc. Financial Data Overview
| 20 | |
| 20.2 | |
| - | |
| 20.3 | |
| 19.8 | |
| 19.8-36.4 | |
| 0 | |
| 0 | |
| 0 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Acepodia, Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Acepodia, Inc. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Acepodia, Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
